Partnering in the Pharma World: BIO-Europe® and industry trends 2012-2015

November 15, 2016

Partnering in the pharma world: BIO-Europe® and industry trends 2012–2015

Pharmaceutical R&D is a costly endeavor associated with high risks as well as immense potential gains. Collaboration within the industry is an often-employed strategy to tackle the major challenges that pharma and biotech companies face, but have there been many shifts within the partnering world, or has it been business as usual? This report combines data from Medtrack with anonymized data from BIO-Europe to identify key trends related to partnering to help you better understand the state, and the power, of collaboration.

Delve into the world of collaboration within the drug development industry to gain insight into strategies for partnered products and drug pipelines.

Download the report now.

Share your email address with EBD Group to open the whitepaper. Unsubscribe to our news at any time. Learn More: EBD Group Terms of Use Privacy Policy

Previous Article
How Do Healthcare Investors and Payers Separate the Tools From the Toys?
How Do Healthcare Investors and Payers Separate the Tools From the Toys?

  Guest post by Nicole Fisher, Founder & CEO at HHR Strategies, Inc., Forbes Contributor The healthcare sec...

Next Article
UK Establishment upbeat about Brexit’s effect on British life science industry
UK Establishment upbeat about Brexit’s effect on British life science industry

Brexit may no longer be at the top of popular news, but it continues to be a key concern for biopharma comp...